Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: Long-term results of a prospective GOELAMS study

Blood

Volumn 119, Issue 12, 2012, Pages 2943-2948

  Lioure, Bruno ^a   Béné, Marie C ^b   Pigneux, Arnaud ^c   Huynh, Anne ^d   Chevallier, Patrice ^e   Fegueux, Nathalie ^f   Blaise, Didier ^g   Witz, Brigitte ^b   Delain, Martine ^h   Cornillon, Jérôme ⁱ   Luquet, Isabelle ^j   Blanchet, Odile ^k   Cornillet Lefebvre, Pascale ^j   Carré, Martin ^l   Hunault, Mathilde ^k   Larosa, Fabrice ^m   Lamy, Thierry ⁿ   Randriamalala, Edouard ^o   Ojeda Uribe, Mario ^p   Berthou, Christian ^q   Fornecker, Luc ^a   Harousseau, Jean Luc ^r   Bouscary, Didier ^s   Ifrah, Norbert ^k   Cahn, Jean Yves ^l   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g INSTITUT PAOLI CALMETTES   (France)

^h UNIVERSITY HOSPITAL OF TOURS   (France)

ⁱ Institut de Cancerologie de la Loire   (France)

^j REIMS UNIVERSITY HOSPITAL   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

^m UNIVERSITY HOSPITAL OF BESANÇON   (France)

ⁿ RENNES UNIVERSITY HOSPITAL   (France)

^o POITIERS UNIVERSITY HOSPITAL   (France)

^p CENTRE HOSPITALIER DE MULHOUSE   (France)

^q BREST UNIVERSITY HOSPITAL   (France)

^r CENTRE RENÉ GAUDUCHEAU   (France)

^s NONE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER REGRESSION; CANCER RELAPSE; CLINICAL TRIAL; DONOR; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SIBLING; TREATMENT PLANNING;

EID: 84858833433     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-05-352989     Document Type: Article

References (17)

1. Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-474.
2. Rowe JM. Optimal induction and post-remission therapy for AML in first remission. Hematology Am Soc Hematol Educ Program. 2009:396-405.
3. Chevallier P, Fornecker L, Lioure B, et al. Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial. Leukemia. 2010;24(7):1380-1385.
4. Brothman AR, Persons DL, Shaffer LG. Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition. Cytogenet Genome Res. 2009;127(1):1-4.
5. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: an easy guide for clinician. Bone Marrow Transplant. 2007;40(4):381-387. (Pubitemid 47202424)
6. Blaise D-P, Boiron J-M, Faucher C, et al. Reduced intensity conditioning prior to allogeneic stem cell transplantation for patients with acute myeloblastic leukemia as a first-line treatment. Cancer. 2005;104(9):1931-1938. (Pubitemid 41513177)
7. Estey E, De Lima M, Tibes R, et al. Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Blood. 2005; 109(4):1395-1400. (Pubitemid 46239569)
8. Blaise D, Vey N, Faucher C, Mohty M. Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica. 2007;92(4): 533-541. (Pubitemid 350147795)
9. Mohty M, de Lavallade H, El-Cheikh J, et al. Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a 'donor'versus 'no donor' comparison. Leukemia. 2009; 23(1):194-196.
10. Koreth J, Aldridge J, Kim H-T, et al. Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. Biol Blood Marrow Transplant. 2010;16(6):792-800.
11. Shimoni A, Hardan I, Shem-Tov N, et al. Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced- intensity conditioning: long-term follow-up. Leukemia. 2010;24(5):1050-1052.
12. Kurosawa S, Yamaguchi T, Uchida, et al. Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission. Biol Blood Marrow Transplant. 2011; 17(3):400-404.
13. Socié G, Clift R-A, Blaise D, et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood. 2001; 98(13):3569-3974.
14. Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. J Am Med Assoc. 2009;301(22):2349-2361.
15. Cahn JY, Labopin M, Schattenberg A, et al. Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia. 1997;11(3):416-419. (Pubitemid 27120992)
16. Gupta V, Tallmann MS, Weisdorf DJ. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns. Blood. 2011;117(8):2307-2318.
17. Guo M, Hu K-X, Yu C-L, et al. Infusion of HLAmismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood. 2011;117(3): 936-940.